John David Finley - Net Worth and Insider Trading
John David Finley Net Worth
The estimated net worth of John David Finley is at least $38,213 dollars as of 2024-05-11. John David Finley is the CEO, CFO, Director of Palisade Bio Inc and owns about 5,695 shares of Palisade Bio Inc (PALI) stock worth over $38,213. Details can be seen in John David Finley's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that John David Finley has not made any transactions after 2024-02-06 and currently still holds the listed stock(s).
Transaction Summary of John David Finley
John David Finley Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John David Finley owns 1 companies in total, including Palisade Bio Inc (PALI) .
Click here to see the complete history of John David Finley’s form 4 insider trades.
Insider Ownership Summary of John David Finley
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PALI | Palisade Bio Inc | 2024-02-06 | Chief Financial Officer |
John David Finley Latest Holdings Summary
John David Finley currently owns a total of 1 stock. John David Finley owns 5,695 shares of Palisade Bio Inc (PALI) as of February 6, 2024, with a value of $38,213.
Latest Holdings of John David Finley
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PALI | Palisade Bio Inc | 2024-02-06 | 5,695 | 6.71 | 38,213 |
Holding Weightings of John David Finley
John David Finley Form 4 Trading Tracker
According to the SEC Form 4 filings, John David Finley has made a total of 10 transactions in Palisade Bio Inc (PALI) over the past 5 years, including 10 buys and 0 sells. The most-recent trade in Palisade Bio Inc is the acquisition of 667 shares on February 6, 2024, which cost John David Finley around $4,700.
Insider Trading History of John David Finley
- 1
John David Finley Trading Performance
GuruFocus tracks the stock performance after each of John David Finley's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John David Finley is -26.24%. GuruFocus also compares John David Finley's trading performance to market benchmark return within the same time period. The performance of stocks bought by John David Finley within 3 months outperforms 2 times out of 10 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how John David Finley's insider trading performs compared to the benchmark.
Performance of John David Finley
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -15.74 | | | | | |
| Relative Return to S&P 500(%) | -12.69 | | | | | |
John David Finley Ownership Network
John David Finley Owned Company Details
What does Palisade Bio Inc do?
Who are the key executives at Palisade Bio Inc?
John David Finley is the Chief Financial Officer of Palisade Bio Inc. Other key executives at Palisade Bio Inc include Chief Medical Officer Mitchell Lawrence Jones , Chief Operating Officer Robert Curtis Mcrae , and director & Chief Executive Officer Thomas Hallam .
Palisade Bio Inc (PALI) Insider Trades Summary
Over the past 18 months, John David Finley made 4 insider transaction in Palisade Bio Inc (PALI) with a net purchase of 50,000. Other recent insider transactions involving Palisade Bio Inc (PALI) include a net purchase of 30,000 shares made by Donald Allen Williams , a net sale of 300 shares made by Robert J. Trenschel ,
In summary, during the past 3 months, insiders sold 0 shares of Palisade Bio Inc (PALI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 20 shares of Palisade Bio Inc (PALI) were sold and 5,333 shares were bought by its insiders, resulting in a net purchase of 5,313 shares.
Palisade Bio Inc (PALI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Palisade Bio Inc Insider Transactions
John David Finley Mailing Address
Above is the net worth, insider trading, and ownership report for John David Finley. You might contact John David Finley via mailing address: C/o Seneca Biopharma, Inc., 20271 Goldenrod Lane, Germantown Md 20876.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
